Matthew Harris
Founder at CLARITY PHARMACEUTICALS LTD
Net worth: 34 M $ as of 2024-04-29
Matthew Harris active positions
Companies | Position | Start | End |
---|---|---|---|
CLARITY PHARMACEUTICALS LTD | Chief Tech/Sci/R&D Officer | 2019-04-02 | - |
Founder | 2009-12-31 | - | |
Director/Board Member | 2009-12-31 | 2019-09-30 | |
Chief Executive Officer | 2009-12-31 | 2019-04-02 |
Career history of Matthew Harris
Former positions of Matthew Harris
Companies | Position | Start | End |
---|---|---|---|
GENERA BIOSYSTEMS LIMITED | Director/Board Member | 2007-11-04 | 2008-12-11 |
Gateway Capital Ltd.
Gateway Capital Ltd. Financial ConglomeratesFinance Gateway Capital Ltd. is an investment firm. | President | - | - |
Training of Matthew Harris
Australian Graduate School of Management | Masters Business Admin |
Australian National University | Doctorate Degree |
Statistics
International
Australia | 6 |
Operational
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
CLARITY PHARMACEUTICALS LTD | Health Technology |
Private companies | 2 |
---|---|
Gateway Capital Ltd.
Gateway Capital Ltd. Financial ConglomeratesFinance Gateway Capital Ltd. is an investment firm. | Finance |
Genera Biosystems Ltd.
Genera Biosystems Ltd. Medical SpecialtiesHealth Technology Genera Biosystems Ltd. is a molecular diagnostics company, which engages in the development and commercialization of molecular diagnostic tests. Its products include PapType and RTIplex. The company was founded by Karl Poetter on November 6, 2001 and is headquartered in Scoresby, Australia. | Health Technology |
- Stock Market
- Insiders
- Matthew Harris
- Experience